α,α-Difluoro-α-(trimethylsilyl)acetamides as Versatile Reagents for the Preparation of Difluorinated Aldol and Mannich Adducts
作者:Aurélien Honraedt、Arie Van Der Lee、Jean-Marc Campagne、Eric Leclerc
DOI:10.1002/adsc.201700371
日期:2017.8.17
The very efficient addition of α,α‐difluoro‐α‐(trimethylsilyl)acetamides to aldehydes, ketones and N‐(tert‐butanesulfinyl)imines is described. The reaction is promoted by a catalytic amount of tetra‐n‐butylammonium diphenyltrifluorosilicate (TBAT) and high yields, as well as very high stereoselectivities in the case of N‐(tert‐butanesulfinyl)imines, are achieved. The synthetic potential of this method
[EN] ANTIMICROBIAL COMPUNDS AND METHODS OF MAKING AND USING THE SAME<br/>[FR] COMPOSÉS ANTIMICROBIENS ET PROCÉDÉS DE FABRICATION ET D'UTILISATION DE CES COMPOSÉS
申请人:MELINTA THERAPEUTICS INC
公开号:WO2015035426A1
公开(公告)日:2015-03-12
The present invention relates generally to the field of antimicrobial compounds and to methods of making and using them. These compounds are useful for treating, preventing, reducing the risk of, and delaying the onset of microbial infections in humans and animals.
Samarium Diiodide-Induced Asymmetric Synthesis of Optically Pure Unsymmetrical Vicinal Diamines by Reductive Cross-Coupling of Nitrones with <i>N</i>-<i>tert</i>-Butanesulfinyl Imines
作者:Yu-Wu Zhong、Ming-Hua Xu、Guo-Qiang Lin
DOI:10.1021/ol048444d
日期:2004.10.1
[reaction: see text] An efficient method for the preparation of opticallypure unsymmetrical vicinal diamines by the SmI(2)-induced reductive cross-coupling of nitrones with chiral N-tert-butanesulfinyl imines was developed. This is the first successful example of the highly diastereoselective and enantioselective cross-coupling between two different imine species. It provides a straightforward access
[EN] ANTIMICROBIAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME<br/>[FR] COMPOSÉS ANTIMICROBIENS ET PROCÉDÉS DE FABRICATION ET MÉTHODES D'UTILISATION DE CEUX-CI
申请人:MELINTA THERAPEUTICS INC
公开号:WO2015035421A1
公开(公告)日:2015-03-12
Methods and compounds for treating, preventing, reducing the risk of, and/or delaying the onset of a microbial infection in a subject are disclosed herein, wherein the microbial infection is caused by one or more microorganisms (e.g., one or more bacteria) which can be used as a biological weapon, such as Bacillus anthracis, Franciscella tularensis, Yersinia pestis, Burkholderia mallei, and Burkholderia pseudomallei. Also disclosed are pharmaceutical compositions or kits for treating, preventing, reducing the risk of and/or delaying the onset of a microbial infection.